InsidersTradesSigma
Follow the 株式会社コスモス薬品 stock price and the full management transaction log of the company, a listed issuer based in Japan. Shares trade on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社コスモス薬品 has recorded 13 public disclosures. Market capitalisation: €507.6bn. The latest transaction was filed on 21 April 2026 (Holding update). Among the most active insiders: JPMorgan Asset Management (Japan) Limited. Every trade is accessible without an account.
13
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 株式会社コスモス薬品 Buy (bullish), based on 10 analysts. Average price target: JP¥7,571.
21Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,223 of 29,063 companies
56.0
score / 100
Value60
Quality52
FCF yld-0.2%
Earn yld6.1%
EV/EBITDA8.6x
ROE12%
Gross mgn21%
Net mgn3.1%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 April 2026
Declarations13 total
ShareXTKSEDINET:S100XZQC
ShareXTKSEDINET:S100XLUY
ShareXTKSEDINET:S100XC3L
ShareXTKSEDINET:S100X83X
ShareXTKSEDINET:S100WYJ7
100.0% of flowShareXTKSEDINET:S100WE9H
ShareXTKSEDINET:S100VYS4
ShareXTKSEDINET:S100VVF0
ShareXTKSEDINET:S100VPMP
ShareXTKSEDINET:S100VPA9
ShareXTKSEDINET:S100VMZ7
ShareXTKSEDINET:S100VMWV
ShareXTKSEDINET:S100QSC3
13 of 13 declarations
关于 株式会社コスモス薬品
Cosmos Pharmaceutical Corporation 是一家日本公司，专门从事药品和保健产品的销售。它主要在日本市场运营，专注于药品和健康产品的分销。